A phase II, multicentre, randomised, double-blind, parallel and controlled with placebo pilot study to evaluate the efficacy and safety of a single dose of botulinum toxin type A (Dysport) associated with rehabilitation treatment, in patients with primary myofascial syndrome of cervical and dorsal localisation.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Myofascial pain
- Focus Therapeutic Use
- Sponsors Ipsen
- 13 Nov 2006 New trial record.